Onxeo

Onxeo S.A.
Stock Exchange Copenhagen Stock Exchange
EPS
DKK1.38
Market Cap
DKK328.23 M
Shares Outstanding
50.91 M
Public Float
-
Onxeo S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.91 M
Public Float
-
Onxeo S.A.
Stock Exchange Euronext Paris
EPS
EUR0.18
Market Cap
EUR43.33 M
Shares Outstanding
54.82 M
Public Float
44.74 M

Profile

Address
49, blvd. du Général Martial Valin
Paris Ile-de-France 75015
France
Employees -
Website http://www.onxeo.com
Updated 07/08/2019
Onxeo SA is a biotechnology company, which engages in the development of drugs for the treatment of orphan diseases. It produces and develops ophan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Gilles Avenard and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.

Financials

View All

Judith Greciet
Chief Executive Officer & Director
Joseph S. Zakrzewski
Non-Executive Chairman